305 related articles for article (PubMed ID: 16964597)
21. Donor and recipient age effect.
Ito T; Iwaki Y; Terasaki PI
Clin Transpl; 1986; ():189-97. PubMed ID: 3154401
[TBL] [Abstract][Full Text] [Related]
22. Underutilization of pancreas donors.
Krieger NR; Odorico JS; Heisey DM; D'Alessandro AM; Knechtle SJ; Pirsch JD; Sollinger HW
Transplantation; 2003 Apr; 75(8):1271-6. PubMed ID: 12717215
[TBL] [Abstract][Full Text] [Related]
23. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia.
Totsuka E; Dodson F; Urakami A; Moras N; Ishii T; Lee MC; Gutierrez J; Gerardo M; Molmenti E; Fung JJ
Liver Transpl Surg; 1999 Sep; 5(5):421-8. PubMed ID: 10477844
[TBL] [Abstract][Full Text] [Related]
24. Liver transplantation from controlled non-heart-beating donors.
D'alessandro AM; Hoffmann RM; Knechtle SJ; Odorico JS; Becker YT; Musat A; Pirsch JD; Sollinger HW; Kalayoglu M
Surgery; 2000 Oct; 128(4):579-88. PubMed ID: 11015091
[TBL] [Abstract][Full Text] [Related]
25. Extensive use of split liver for pediatric liver transplantation: a single-center experience.
Spada M; Gridelli B; Colledan M; Segalin A; Lucianetti A; Petz W; Riva S; Torre G
Liver Transpl; 2000 Jul; 6(4):415-28. PubMed ID: 10915162
[TBL] [Abstract][Full Text] [Related]
26. Poor initial graft function after orthotopic liver transplantation: can it be predicted and does it affect outcome? An analysis of 125 adult primary transplantations.
Maring JK; Klompmaker IJ; Zwaveling JH; Kranenburg K; Ten Vergert EM; Slooff MJ
Clin Transplant; 1997 Oct; 11(5 Pt 1):373-9. PubMed ID: 9361926
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus infection in liver allografts.
Randhawa PS; Demetris AJ
Pathol Annu; 1995; 30 Pt 2():203-26. PubMed ID: 8570276
[TBL] [Abstract][Full Text] [Related]
28. Outcome of the use of pediatric donor livers in adult recipients.
Yasutomi M; Harmsmen S; Innocenti F; DeSouza N; Krom RA
Liver Transpl; 2001 Jan; 7(1):38-40. PubMed ID: 11150420
[TBL] [Abstract][Full Text] [Related]
29. Marginal grafts: finding the correct treatment for fatty livers.
Salizzoni M; Franchello A; Zamboni F; Ricchiuti A; Cocchis D; Fop F; Brunati A; Cerutti E
Transpl Int; 2003 Jul; 16(7):486-93. PubMed ID: 12669196
[TBL] [Abstract][Full Text] [Related]
30. Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation.
Sreekumar R; Rasmussen DL; Wiesner RH; Charlton MR
Liver Transpl; 2002 Sep; 8(9):814-21. PubMed ID: 12200784
[TBL] [Abstract][Full Text] [Related]
31. Increased risk of antibody-mediated rejection of reduced-size liver allografts.
Astarcioglu I; Cursio R; Reynes M; Gugenheim J
J Surg Res; 1999 Dec; 87(2):258-62. PubMed ID: 10600358
[TBL] [Abstract][Full Text] [Related]
32. Expanded liver donor age over 60 years for hepatic transplantation.
Grande L; Matus D; Rimola A; Manyalic M; Cabrer C; García-Valdecasas JC; Visa J
Clin Transpl; 1998; ():297-301. PubMed ID: 10503107
[TBL] [Abstract][Full Text] [Related]
33. Liver transplantation at Stanford University Medical Center.
Millan MT; Keeffe EB; Berquist WE; Castillo RO; Cox KL; Garcia G; Imperial JC; Monge H; So SK; Esquivel CO
Clin Transpl; 1998; ():287-96. PubMed ID: 10503106
[TBL] [Abstract][Full Text] [Related]
34. Putative survival predictors in right-graft (adult) recipients after in situ split-liver transplantation: a retrospective single-center analysis.
Santori G; Andorno E; Antonucci A; Morelli N; Panaro F; Valente U
Transpl Int; 2003 Jul; 16(7):476-85. PubMed ID: 12690436
[TBL] [Abstract][Full Text] [Related]
35. [Liver transplantation using grafts from donors over 65].
Gomez R; Moreno E; Loinaz C; González-Pinto I; García I; Marcello M; Castellón C; Lumbreras C; Colina F; Manzanera M
Rev Esp Enferm Dig; 1995 Mar; 87(3):217-20. PubMed ID: 7742051
[TBL] [Abstract][Full Text] [Related]
36. HCV+ donors: should they be used for organ transplantation?
Aswad S; Obispo E; Mendez RG; Mendez R
Transplant Proc; 1993 Dec; 25(6):3072-4. PubMed ID: 8266457
[No Abstract] [Full Text] [Related]
37. Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients.
Lumbreras C; Sanz F; González A; Pérez G; Ramos MJ; Aguado JM; Lizasoain M; Andrés A; Moreno E; Gómez MA; Noriega AR
Clin Infect Dis; 2001 Sep; 33(5):722-6. PubMed ID: 11477528
[TBL] [Abstract][Full Text] [Related]
38. The effect of donor gender on graft survival.
Zeier M; Döhler B; Opelz G; Ritz E
J Am Soc Nephrol; 2002 Oct; 13(10):2570-6. PubMed ID: 12239247
[TBL] [Abstract][Full Text] [Related]
39. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C.
Wali M; Harrison RF; Gow PJ; Mutimer D
Gut; 2002 Aug; 51(2):248-52. PubMed ID: 12117889
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of potential liver donors: limits imposed by donor variables in liver transplantation.
Rull R; Vidal O; Momblan D; González FX; López-Boado MA; Fuster J; Grande L; Bruguera M; Cabrer K; García-Valdecasas JC
Liver Transpl; 2003 Apr; 9(4):389-93. PubMed ID: 12682892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
